Market Overview

UPDATE: Pfizer Posts Upbeat Q4 Profit

Related PFE
UPDATE: Protalix Shares Spike Higher on FDA Approval of Pediatric Indication for ELELYSO(TM) for Injection, for IV Use for Treatment of Type 1 Gaucher Disease
Fast Money Picks For August 28
Treasury Develolping Options to Curb Inversions (Fox Business)

Pfizer (NYSE: PFE) reported a drop in its fiscal fourth-quarter profit.

Pfizer's quarterly profit declined to $2.57 billion, or $0.39 per share, from a year-ago profit of $6.32 billion, or $0.85 per share. Its adjusted profit climbed to $0.56 from $0.46 per share.

Its revenue dropped 2% to $13.56 billion versus $13.89 billion. However, analysts were estimating earnings of $0.52 per share on revenue of $13.36 billion.

Pfizer projects 2014 adjusted earnings of $2.20 to $2.30 per share on revenue of $49.2 billion to $51.2 billion.

Pfizer shares gained 1.62% to $30.14 in pre-market trading.

Posted-In: profitEarnings News Guidance

 

Related Articles (PFE)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional